ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327,740 | -8.2% | 3,500 | -12.5% | 0.00% | -100.0% |
| Q2 2023 | $357,000 | -84.7% | 4,000 | -81.7% | 0.00% | -80.0% |
| Q1 2023 | $2,337,396 | +18.9% | 21,800 | +35.4% | 0.01% | -16.7% |
| Q4 2022 | $1,966,293 | +495.8% | 16,100 | +403.1% | 0.01% | +500.0% |
| Q3 2022 | $330,000 | -9.1% | 3,200 | -17.9% | 0.00% | 0.0% |
| Q2 2022 | $363,000 | -74.2% | 3,900 | -67.5% | 0.00% | -80.0% |
| Q1 2022 | $1,408,000 | +110.5% | 12,000 | +185.7% | 0.01% | +66.7% |
| Q3 2021 | $669,000 | +58.9% | 4,200 | +31.2% | 0.00% | +50.0% |
| Q2 2021 | $421,000 | -16.3% | 3,200 | -17.9% | 0.00% | 0.0% |
| Q1 2021 | $503,000 | +11.8% | 3,900 | +44.4% | 0.00% | 0.0% |
| Q4 2020 | $450,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |